| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A natural anatoxin, Amm VIII, induces neutralizing antibodies against the potent scorpion alpha-toxins
|
Martin-Eauclaire, M.-F.
|
|
2006
|
24 |
12 |
p. 1990-1996
7 p.
|
article
|
| 2 |
A novel strategy to compensate the disadvantages of live vaccine using suicide-gene system and provide better antitumor immunity
|
Kang, Yu
|
|
2006
|
24 |
12 |
p. 2141-2150
10 p.
|
article
|
| 3 |
Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2–7 months of age
|
Scheifele, David W.
|
|
2006
|
24 |
12 |
p. 2057-2064
8 p.
|
article
|
| 4 |
Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG
|
Xu, Long Bing
|
|
2006
|
24 |
12 |
p. 2131-2140
10 p.
|
article
|
| 5 |
Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice
|
Konishi, Eiji
|
|
2006
|
24 |
12 |
p. 2200-2207
8 p.
|
article
|
| 6 |
Diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic disorders in 8–12-year-old children
|
Bernsen, Roos M.D.
|
|
2006
|
24 |
12 |
p. 2035-2042
8 p.
|
article
|
| 7 |
DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus
|
Nour El-Din, Adel N.M.
|
|
2006
|
24 |
12 |
p. 1997-2006
10 p.
|
article
|
| 8 |
DNA vaccines for therapy of tuberculosis: Where are we now?
|
Lowrie, Douglas B.
|
|
2006
|
24 |
12 |
p. 1983-1989
7 p.
|
article
|
| 9 |
Editorial board
|
|
|
2006
|
24 |
12 |
p. CO2-
1 p.
|
article
|
| 10 |
Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant
|
Borsutzky, Stefan
|
|
2006
|
24 |
12 |
p. 2049-2056
8 p.
|
article
|
| 11 |
Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice
|
Wang, Fang
|
|
2006
|
24 |
12 |
p. 2017-2026
10 p.
|
article
|
| 12 |
Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant
|
Kende, Meir
|
|
2006
|
24 |
12 |
p. 2213-2221
9 p.
|
article
|
| 13 |
Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine
|
Wang, Keyang
|
|
2006
|
24 |
12 |
p. 2176-2185
10 p.
|
article
|
| 14 |
Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco
|
Almquist, Kurt C.
|
|
2006
|
24 |
12 |
p. 2079-2086
8 p.
|
article
|
| 15 |
Fish soluble Toll-like receptor (TLR)5 amplifies human TLR5 response via physical binding to flagellin
|
Tsujita, Tadayuki
|
|
2006
|
24 |
12 |
p. 2193-2199
7 p.
|
article
|
| 16 |
Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing process
|
Buonagurio, Deborah A.
|
|
2006
|
24 |
12 |
p. 2151-2160
10 p.
|
article
|
| 17 |
Hepatitis B revaccination in healthy non-responder Chinese children: Five-year follow-up of immune response and immunologic memory
|
Zhuang, Gui-Hua
|
|
2006
|
24 |
12 |
p. 2186-2192
7 p.
|
article
|
| 18 |
HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics
|
Newman, Peter A.
|
|
2006
|
24 |
12 |
p. 2094-2101
8 p.
|
article
|
| 19 |
Immune response induced by Salmonella typhimurium defective in ppGpp synthesis
|
Na, Hee Sam
|
|
2006
|
24 |
12 |
p. 2027-2034
8 p.
|
article
|
| 20 |
Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge
|
Govan, V.A.
|
|
2006
|
24 |
12 |
p. 2087-2093
7 p.
|
article
|
| 21 |
Immunization by particle bombardment of antigen-loaded poly-(dl-lactide-co-glycolide) microspheres in mice
|
Uchida, Masaki
|
|
2006
|
24 |
12 |
p. 2120-2130
11 p.
|
article
|
| 22 |
Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A
|
Nakano, Hideki
|
|
2006
|
24 |
12 |
p. 2110-2119
10 p.
|
article
|
| 23 |
Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-142 using human compatible adjuvants
|
Sachdeva, Suraksha
|
|
2006
|
24 |
12 |
p. 2007-2016
10 p.
|
article
|
| 24 |
Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population
|
Knuf, Markus
|
|
2006
|
24 |
12 |
p. 2043-2048
6 p.
|
article
|
| 25 |
Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity
|
Cornet, Sébastien
|
|
2006
|
24 |
12 |
p. 2102-2109
8 p.
|
article
|
| 26 |
Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis
|
Aldwell, F.E.
|
|
2006
|
24 |
12 |
p. 2071-2078
8 p.
|
article
|
| 27 |
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis
|
Rafati, Sima
|
|
2006
|
24 |
12 |
p. 2169-2175
7 p.
|
article
|
| 28 |
Progress in the control of hepatitis B infection in the Western Pacific Region
|
Clements, C. John
|
|
2006
|
24 |
12 |
p. 1975-1982
8 p.
|
article
|
| 29 |
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
|
Vollmar, Jens
|
|
2006
|
24 |
12 |
p. 2065-2070
6 p.
|
article
|
| 30 |
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens
|
Jacobsson, Susanne
|
|
2006
|
24 |
12 |
p. 2161-2168
8 p.
|
article
|
| 31 |
Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants
|
Sasaki, Yuka
|
|
2006
|
24 |
12 |
p. 2208-2212
5 p.
|
article
|
Journal description